The α2-adrenoceptor antagonist yohimbine reduces glial fibrillary acidic protein upregulation induced by chronic morphine administration

Neuroscience Letters

Volumn 383, Issue 1-2, 2005, Pages 141-144

  Garrido, Elisa ^a   Pérez García, Carmen ^a   Alguacil, Luis F ^a   Díez Fernández, Carmen ^a  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

Author keywords

Glial fibrillary acidic protein; Morphine; Neurotoxicity; Yohimbine

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; GLIAL FIBRILLARY ACIDIC PROTEIN; MORPHINE; YOHIMBINE; NARCOTIC AGENT;

ALPHA ADRENERGIC RECEPTOR BLOCKING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BRAIN PROTECTION; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; FRONTAL CORTEX; IMMUNOHISTOCHEMISTRY; LONG TERM EXPOSURE; MALE; NEUROTOXICITY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SPECIES COMPARISON; UPREGULATION; VENTRAL TEGMENTUM; ANALYSIS OF VARIANCE; ANIMAL; BRAIN; COMPARATIVE STUDY; DRUG EFFECT; DRUG INTERACTION; GENETICS; METABOLISM; METHODOLOGY; SPRAGUE DAWLEY RAT;

ADRENERGIC ALPHA-ANTAGONISTS; ANALYSIS OF VARIANCE; ANIMALS; BRAIN; DRUG INTERACTIONS; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; MALE; MORPHINE; NARCOTICS; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION; YOHIMBINE;

EID: 20344372156     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.04.002     Document Type: Article

References (31)

1. N. Aguirre, M. Barrionuevo, M.J. Ramirez, J. Del Rio, and B. Lasheras Alpha-lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity NeuroReport 10 1999 3675 3680
2. L.F. Alguacil, and L. Morales Alpha-2 adrenoceptor ligands and opioid drugs: pharmacological interactions of therapeutic interest Curr. Neuropharmacol. 2 2004 343 352
3. D. Beitner-Johnson, and E.J. Nestler Chronic morphine impairs axoplasmic transport in the rat mesolimbic dopamine system NeuroReport 5 1993 57 60
4. 2- imidazoline ligands Br. J. Pharmacol. 125 1998 175 185
5. A.O.S. El-Kadi, and S.I. Sharif The influence of chronic treatment with clonidine, yohimbine and idazoxan on morphine withdrawal Psychopharmacology 132 1997 67 73
6. L.F. Eng, R.S. Ghirnikar, and Y.L. Lee Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000) Neurochem. Res. 25 2000 1439 1451
7. X.L. Fan, J.S. Zhang, X.Q. Zhang, W. Yue, and L. Ma Differential regulation of beta-arrestin 1 and beta-arrestin 2 gene expression in rat brain by morphine Neuroscience 117 2003 383 389
8. L. Fattore, M.C. Puddu, S. Picciau, A. Cappai, W. Fratta, G.P. Serra, and S. Spiga Astroglial in vivo response to cocaine in mouse dentate gyrus: a quantitative and qualitative analysis by confocal microscopy Neuroscience 110 2002 1 6
9. H. Franke Influence of chronic alcohol treatment on the GFAP-immunoreactivity in astrocytes of the hippocampus in rats Acta Histochem. 97 1995 263 271
10. L.R. Gowing, M. Farrell, R.L. Ali, and J.M. White Alpha2-adrenergic agonists in opioid withdrawal Addiction 97 2002 49 58
11. V. Iglesias, C. Alamo, E. Cuenca, L. Morales, C. Perez-Garcia, and L.F. Alguacil Effect of oral yohimbine on withdrawal jumping behaviour of morphine-dependent mice Addict. Biol. 3 1998 459 463
12. V. Iglesias, L.F. Alguacil, C. Alamo, and E. Cuenca Effects of yohimbine on morphine analgesia and physical dependence in the rat Eur. J. Pharmacol. 211 1992 35 38
13. A.M. Janson, and A. Moller Chronic nicotine treatment counteracts nigral cell loss induced by a partial mesodiencephalic hemitransection: an analysis of the total number and mean volume of neurons and glia in substantia nigra of the male rat Neuroscience 57 1993 931 941
14. H.K. Kimelberg, and M.D. Norenberg Astrocytes Sci. Am. 4 1989 66 76
15. M.L. Laorden, G. Fuertes, A. González-Cuello, and M.V. Milanés Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence. Implication of alpha-1 and alpha-2 adrenoceptors J. Pharmacol. Exp. Ther. 293 2000 578 584
16. N. Ma, M.C. Madigan, T. Chan-Ling, and N.H. Hunt Compromised blood-nerve barrier, astrogliosis, and myelin disruption in optic nerves during fatal murine cerebral malaria Glia 19 1997 135 151
17. C. Marie-Claire, C. Courtin, B.P. Roques, and F. Noble Cytoskeletal genes regulation by chronic morphine treatment in rat striatum Neuropsychopharmacology 16 2004 1 8
18. L. Morales, C. Perez-Garcia, and L.F. Alguacil Effects of yohimbine on the antinociceptive and place conditioning effects of opioid agonists in rodents Br. J. Pharmacol. 133 2001 172 178
19. E.J. Nestler Historical review: molecular and cellular mechanisms of opiate and cocaine addiction Trends Pharmacol. Sci. 25 2004 210 218
20. J.E. Nestler, S.E. Hyman, and R.C. Malenka Reinforcement and addictive disorders J.E. Nestler S.E. Hyman R.C. Malenka Molecular Neuropharmacology. A Foundation for Clinical Neuroscience 2001 The McGraw-Hill International USA 355 382
21. J.P. O'Callaghan, and K.F. Jensen Enhanced expression of glial fibrillary acidic protein and the cupric silver degeneration reaction can be used as sensitive and early indicators of neurotoxicity Neurotoxicology 13 1992 113 122
22. Y. Okimura, H. Tanno, K. Fukuda, M. Ohga, M. Nakamura, N. Aihara, and A. Yamaura Reactive astrocytes in acute stage after experimental brain injury: relationship to extravasated plasma protein and expression of heat shock protein J. Neurotrauma 13 1996 385 393
23. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 1986 Academic Press New York
24. C. Post, T. Archer, and B.G. Minor Evidence for crosstolerance to the analgesic effects between morphine and selective alpha 2-adrenoceptor agonists J. Neural Transm. 72 1988 1 9
25. P. Song, and Z.Q. Zhao The involvement of glial cells in the development of morphine tolerance Neurosci. Res. 39 2001 281 286
26. S.M. Stine, S.M. Southwick, I.L. Petrakis, T.R. Kosten, D.S. Charney, and J.H. Krystal Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients Biol. Psychiatry 51 2002 642 651
27. I. Suarez, G. Bodega, J.A. Ramos, J.J. Fernandez-Ruiz, and B. Fernández Neuronal and astroglial response to pre- and perinatal exposure to delta-9-tetra- hydrocannabinol in the rat substantia nigra Dev. Neurosci. 22 2000 253 263
28. J.R. Taylor, V.O. Lewis, J.D. Elsworth, P. Pivirotto, R.H. Roth, and D.E.J. Redmond Yohimbine co-treatment during chronic morphine administration attenuates naloxone precipitated withdrawal without diminishing tail-flick analgesia in rats Psychopharmacology 103 1991 407 414
29. J.M. Van Ree, M.A. Gerrits, and L.J. Vanderschuren Opioids, reward and addiction: an encounter of biology, psychology, and medicine Pharmacol. Rev. 51 1999 341 396
30. T.J. Vries de, and T.S. Shippenberg Neural systems underlying opiate addiction J. Neurosci. 22 2002 3321 3325
31. A. Yamazaki, and H. Kaneto Single dose tolerance to the analgesic effect of clonidine and cross-tolerance between morphine and clonidine Jpn. J. Pharmacol. 39 1985 461 465